Mitesco Appoints Mr. Allen Plunk to its Board of Directors Jul 18, 2023 10:22AM
Mitesco Inc. Appoints Sheila Schweitzer Chairman of the Board and COO Jun 6, 2023 08:00AM
Mitesco Moves Emphasis to Acquisitions & Strategic Initiatives May 16, 2023 10:53AM
Update: Mitesco, Inc. Continues on Uplist Path, Evaluates Potential Joint Venture and Alternative Funding Opportunities for The Good Clinic Business Dec 19, 2022 10:30AM
Mitesco, Inc. Continues on Uplist Path, Evaluates Potential Joint Venture and Alternative Funding Opportunities for The Good Clinic Business Dec 19, 2022 08:30AM


Dec 9, 2022 04:05PM Mitesco, Inc. Sets Stock Split Date, Readies for Uplist, Increases Shareholders Equity
Jul 15, 2022 09:51AM Mitesco, Inc. Named Blazer Winner at 2022 Minne Inno Fire Awards
Apr 12, 2022 07:00AM CEO Presenting on the Emerging Growth Conference on April 13 Register Now
Oct 27, 2021 01:41PM Mitesco Board of Directors and The Good Clinic™ Executives Share Industry Outlook and the Business Opportunity
Sep 1, 2016 09:01AM Amgen (AMGN) Acquires Global AMG 420 Rights from Boehringer Ingelheim
Sep 1, 2016 09:00AM Amgen Obtains Global Development And Commercial Rights From Boehringer Ingelheim For Investigational BiTE® Immuno-Oncology Drug For Multiple Myeloma
Sep 1, 2016 09:00AM Amgen Obtains Global Development And Commercial Rights From Boehringer Ingelheim For Investigational BiTE® Immuno-Oncology Drug For Multiple Myeloma